MINNEAPOLIS--(BUSINESS WIRE)--ACIST Medical Systems, leading the market in variable-rate, automated contrast delivery systems used in cardiac and vascular angiography, announced the recent publication of a clinical study which showed that use of lower volumes of contrast media while using the ACIST Contrast Delivery System was associated with a reduced relative risk of Contrast Induced Nephropathy (CIN). The study, Automated Contrast Injection in Contemporary Practice during Cardiac Catheterization and PCI: Effects on Contrast-Induced Nephropathy, by Jason Call, et al, was published in the October 2006 issue of the Journal of Invasive Cardiology (Volume 18, Number 10, pages 469-474.) This study is believed to be “the first study to demonstrate that methods to reduce contrast use and strategies to minimize CIN are associated with a lower incidence of CIN and Acute Renal Failure (ARF) after diagnostic catheterization and PCI procedures,” according to the study authors.
